Novartis has announced it is acquiring Gyroscope Therapeutics, the UK-based company behind an investigational dry ADM gene therapy that is...
Read moreIn a wide-ranging interview, PETER LARSEN details his rationale for bringing Specsavers to Australia, as well as the opposition he’s...
Read moreOphthalmic products are a significant contributor to AFT Pharmaceuticals’ bottom line. Combined with an unmet need for preservative-free products, the...
Read moreThe NSW Government has announced a further easing of restrictions, with masks no longer required in retail and clinical spaces...
Read moreMost independent practice owners want to place their business in the safe hands of a new owner who can take...
Read moreSharing an image of an unusual presentation with a colleague may be valuable in the diagnostic process. But Avant’s RUANNE...
Read moreAustralia’s competition watchdog has warned private health insurers they must fulfil their commitment to return all profits due to COVID-19...
Read moreOptometry practices across the country are gearing up for a busy Christmas period, with pent up demand to make this...
Read moreFrench luxury goods company LVMH has reached an agreement to acquire Marcolin's 49% stake in their joint-venture, Thélios, increasing the...
Read moreEssilorLuxottica has announced it now holds an almost 100% stake in GrandVision after the completion of a mandatory public offer...
Read moreInsight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.
© 2024 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited
© 2024 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited